A way to flip cancer cells backward, to undo their transformation
At South Korea's KAIST, biologist Kwang-Hyun Cho and his team have identified a molecular switch capable of reversing the transformation of cancer cells back into healthy ones — not by destroying what has gone wrong, but by returning it to what once was right. Their work centers on a fleeting moment of instability during tumor development, a threshold where the fate of a cell has not yet been sealed. In finding this window, they have challenged one of medicine's longest-held assumptions: that cancer's progression is a one-way door.
- Cancer has long been treated as irreversible — Cho's team is now arguing that the transformation has a hidden undo button.
- The key tension lies in timing: there exists a brief, unstable window where normal and cancerous cells coexist, and that window is where intervention becomes possible.
- Using computational systems biology, researchers mapped the genetic network governing tumor development and successfully reverted colon cancer cells to a healthy state in laboratory trials.
- The method does not kill cancer — it persuades malignant cells to remember their former, healthy identity, a fundamentally different philosophy of treatment.
- The team believes this principle extends beyond colon cancer, suggesting each cancer type may harbor its own molecular switch awaiting discovery.
Kwang-Hyun Cho, a biologist at South Korea's Korea Advanced Institute of Science & Technology, has spent years searching for something most researchers considered impossible: a way to reverse cancer rather than simply destroy it. His team has now found what they believe is a molecular switch — a point of intervention embedded in the very moment cells begin their transformation into malignancy.
The concept rests on what scientists call critical transition. Just as water shifts suddenly to steam at a precise temperature, cells undergoing cancerous change reach a tipping point where they cross from normal to malignant. Cho's team discovered that at this crossing, there exists an unstable window — a brief coexistence of both cell states — where the process can still be turned back.
Using systems biology, the researchers built a computational model of the genetic network governing tumor development, then asked a deceptively simple question: can we reverse the transition rather than merely observe it? Testing on colon cancer cells in the laboratory, they demonstrated that cells mid-transformation could be reverted to healthy, normal states.
What the research ultimately proposes is a new philosophy of cancer treatment — not attacking tumors, but persuading cells to remember what they were before illness took hold. Cho's team believes the same principle applies across multiple cancer types, each with its own critical transition and its own switch waiting to be found. Published in Advanced Science, the work is already pointing toward broader application. The molecular switch has been identified. The work of turning it into medicine has only just begun.
Kwang-Hyun Cho, a biologist at South Korea's Korea Advanced Institute of Science & Technology, stood at the threshold of something that has eluded cancer researchers for decades: a way to flip cancer cells backward, to undo their transformation and return them to health. His team had identified what amounts to a molecular switch—a point of intervention hidden in the moment when normal cells begin their irreversible slide into malignancy.
The discovery hinges on understanding a phenomenon called critical transition. Think of water boiling in a kettle: at exactly 212 degrees Fahrenheit, a sudden shift occurs. The liquid becomes steam. There is no gradual middle ground. Cancer development works similarly. As cells accumulate genetic and epigenetic damage over time, they reach a tipping point—a critical transition—where they cross from normal to cancerous. But Cho's team found something unexpected in that crossing: a window of instability where normal and cancer cells coexist in the same space, neither fully committed to either fate.
This unstable zone is where the intervention becomes possible. Using systems biology, the researchers built a computational model of the genetic network that governs tumor development. They mapped the switches and levers of that network, then asked a deceptively simple question: if we can identify the moment of transition, can we reverse it? They tested their approach on colon cancer cells in the laboratory. The cells that had begun their transformation into malignancy could be reverted. They recovered the characteristics of normal, healthy cells.
What makes this work significant is not just the result but the insight it reveals. For years, cancer's progression has been treated as a mystery—a one-way door that, once opened, cannot be closed. Cho's research suggests the door has a lock, and the lock has a key. The critical transition moment, he explained, is where that key fits. It is the instant when cells are most vulnerable to being turned back, before the transformation becomes truly irreversible.
The team's method works by inferring the genetic network that controls whether a cell becomes cancerous, then identifying the molecular switch within that network that can reverse the process. In their colon cancer trial, they demonstrated proof of concept. The next step is broader application. Cho and his colleagues believe the same principle could work across multiple cancer types—that each form of cancer has its own critical transition, its own molecular switch waiting to be found and flipped.
This is not a cure in the traditional sense. It is not about killing cancer cells or destroying tumors. It is about persuading cells to remember what they were before they became sick. The implications are profound. Rather than attacking cancer with chemotherapy or radiation, future treatments might work by identifying that moment of transition and intervening to reverse it, coaxing malignant cells back toward normalcy. The research has been published in Advanced Science, and the team is already looking ahead to how this technology might be adapted for other cancers. For now, the molecular switch has been found. The question is how quickly it can be turned into medicine.
Citas Notables
We have discovered a molecular switch that can revert the fate of cancer cells back to a normal state by capturing the moment of critical transition right before normal cells are changed into an irreversible cancerous state.— Kwang-Hyun Cho, biologist and paper author at KAIST
This is the first study to reveal that an important clue that can revert the fate of tumorigenesis is hidden at this very moment of change.— Kwang-Hyun Cho
La Conversación del Hearth Otra perspectiva de la historia
So they found a moment when cancer cells can be turned back into normal cells. How is that different from just killing the cancer?
It's fundamentally different. Killing cancer means destroying the cell entirely. This is about changing what the cell is—convincing it to go back to being healthy. It's like rewinding a process instead of stopping it.
But cancer cells have already accumulated all this genetic damage. How can you just undo that?
The key is timing. There's a critical moment right before the transformation becomes permanent, when the cell is still unstable, still caught between two states. That's the window. If you can catch it there and flip the switch, the cell can remember how to be normal again.
They tested this on colon cancer. Does that mean it only works on colon cancer?
They tested it on colon cancer to prove the concept works. But the researchers believe every cancer type has its own critical transition moment, its own switch. The method they developed is a way to find those switches in other cancers too.
What happens next? Is this going to be a treatment soon?
Not immediately. This is foundational research—they've shown the principle works in the lab. Now comes the harder part: figuring out how to actually target that molecular switch in living patients, and whether it works as well in the body as it does in a petri dish.
If it does work, what would treatment look like?
Instead of chemotherapy poisoning cells, you'd be giving patients something that essentially tells their cancer cells to become normal again. It's a completely different approach to the problem.